Stock A001360 SAMSUNG PHARM. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart SAMSUNG PHARM. Co., LTD.

Equities

A001360

KR7001360007

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 20/05/2024 am IST 		5-day change 1st Jan Change
1,681 KRW -0.71% Intraday chart for SAMSUNG PHARM. Co., LTD. -0.88% -22.71%
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
2023 NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
SAMSUNG PHARM. CO., LTD.
Generic Pharmaceuticals
-0.71%-0.88%-22.71%-39.53%-36.20% 12Cr
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. A001360 Stock
  4. Charts SAMSUNG PHARM. Co., LTD.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW